|
NPAT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.843270E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.823940E-02 |
| Normal-vs-Stage2 |
1.774360E-01 |
| Normal-vs-Stage3 |
1.67787999999502E-05 |
| Normal-vs-Stage4 |
5.93059999998147E-07 |
| Stage1-vs-Stage2 |
9.473600E-01 |
| Stage1-vs-Stage3 |
3.439100E-03 |
| Stage1-vs-Stage4 |
8.989500E-04 |
| Stage2-vs-Stage3 |
1.456000E-01 |
| Stage2-vs-Stage4 |
6.313500E-02 |
| Stage3-vs-Stage4 |
4.645200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.423600E-04 |
| Normal-vs-AfricanAmerican |
3.766700E-04 |
| Normal-vs-Asian |
6.756400E-01 |
| Caucasian-vs-AfricanAmerican |
2.368600E-01 |
| Caucasian-vs-Asian |
4.692000E-01 |
| AfricanAmerican-vs-Asian |
2.254000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.73199999999563E-05 |
| Normal-vs-Female |
5.623200E-03 |
| Male-vs-Female |
2.529200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.960600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.330170E-02 |
| Normal-vs-Age(61-80Yrs) |
7.96750000000568E-05 |
| Normal-vs-Age(81-100Yrs) |
6.500000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.434000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.274200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.716600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.931500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.903400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.823600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.215800E-01 |
| Normal-vs-Grade 2 |
8.619500E-02 |
| Normal-vs-Grade 3 |
6.92359999998615E-07 |
| Normal-vs-Grade 4 |
7.8726999996892E-07 |
| Grade 1-vs-Grade 2 |
2.524200E-01 |
| Grade 1-vs-Grade 3 |
1.861700E-03 |
| Grade 1-vs-Grade 4 |
1.504990E-03 |
| Grade 2-vs-Grade 3 |
5.956400E-04 |
| Grade 2-vs-Grade 4 |
1.635740E-04 |
| Grade 3-vs-Grade 4 |
1.147600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.291200E-01 |
| Normal-vs-ccB subtype |
3.59490000000351E-05 |
| ccA subtype-vs-ccB subtype |
1.198190E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.357320E-03 |
| Normal-vs-N1 |
8.224800E-03 |
| N0-vs-N1 |
3.195200E-01 |
|
|
